Yuzheng Zhou
Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.
Journal: Molecular cancer
Published: September 12, 2025
Albendazole Suppresses SARS-CoV-2 Replication by Enhancing HERC5-Mediated ISGylation of Nucleocapsid Protein.
Journal: Journal of medical virology
Published: August 12, 2025
MELK inhibition disrupts actin cytoskeleton and broadly restricts human coronavirus infections.
Journal: Nature communications
Published: June 27, 2025
Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
Journal: Acta pharmaceutica Sinica. B
Published: March 12, 2025
Coronaviral nsp6 hijacks ERAD machinery to facilitate lipolysis and supply membrane components for DMV growth.
Journal: Nature communications
Published: February 24, 2025
Interferon-stimulated gene GALNT2 restricts respiratory virus infections.
Journal: Nature microbiology
Published: December 03, 2024
Ubiquitination: A Double-Edged Mechanism in Coronavirus Infections.
Journal: Journal of medical virology
Published: August 02, 2024
E3 ubiquitin ligase FBXO22 inhibits SARS-CoV-2 replication via promoting proteasome-dependent degradation of NSP5.
Journal: Journal of medical virology
Published: June 30, 2024
Lung-Targeted Lipid Nanoparticle-Delivered siUSP33 Attenuates SARS-CoV-2 Replication and Virulence by Promoting Envelope Degradation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2024
Discovery of meisoindigo derivatives as noncovalent and orally available Mpro inhibitors: their therapeutic implications in the treatment of COVID-19.
Journal: European journal of medicinal chemistry
Published: February 16, 2024
Last Updated: 09/26/2026